CLINICAL_TRIALS
trial_result
· 2018-12-19
Clinical Trial Update: Effect of Zoledronic Acid on Femoral Bone Loss Following Total Hip Arthroplasty [Phase 4]
Summary
Phase 4 trial evaluating the effect of zoledronic acid on femoral bone loss after total hip arthroplasty; results posted after completion.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Spokane Joint Replacement Center | Conditions: Osteoporosis | Phase 4 | Status: COMPLETED | Results posted: 2018-12-19